163 related articles for article (PubMed ID: 31905803)
1. Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model.
Terasaki M; Ikuta M; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905803
[TBL] [Abstract][Full Text] [Related]
2. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
[TBL] [Abstract][Full Text] [Related]
3. Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin.
Terasaki M; Ono S; Hashimoto S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2022 Jan; 99():108871. PubMed ID: 34571188
[TBL] [Abstract][Full Text] [Related]
4. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice.
Terasaki M; Uehara O; Ogasa S; Sano T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
Carcinogenesis; 2021 Feb; 42(2):210-219. PubMed ID: 32940665
[TBL] [Abstract][Full Text] [Related]
5. Continuity of Tumor Microenvironmental Suppression in AOM/DSS Mice by Fucoxanthin May Be Able to Track With Salivary Glycine.
Terasaki M; Kimura R; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2020; 34(6):3205-3215. PubMed ID: 33144425
[TBL] [Abstract][Full Text] [Related]
6. A Biscuit Containing Fucoxanthin Prevents Colorectal Carcinogenesis in Mice.
Terasaki M; Murase W; Kamakura Y; Kawakami S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
Nutr Cancer; 2022; 74(10):3651-3661. PubMed ID: 35695489
[TBL] [Abstract][Full Text] [Related]
7. Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
Terasaki M; Masaka S; Fukada C; Houzaki M; Endo T; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2019; 33(2):365-374. PubMed ID: 30804114
[TBL] [Abstract][Full Text] [Related]
8. Induction of Anoikis in Human Colorectal Cancer Cells by Fucoxanthinol.
Terasaki M; Maeda H; Miyashita K; Mutoh M
Nutr Cancer; 2017 Oct; 69(7):1043-1052. PubMed ID: 28990814
[TBL] [Abstract][Full Text] [Related]
9. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
10. Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice.
Grill JI; Neumann J; Ofner A; Marschall MK; Zierahn H; Herbst A; Wolf E; Kolligs FT
Carcinogenesis; 2018 Sep; 39(9):1176-1184. PubMed ID: 29901779
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated
Terasaki M; Hamoya T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
Anticancer Res; 2021 Mar; 41(3):1299-1305. PubMed ID: 33788721
[TBL] [Abstract][Full Text] [Related]
12. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.
Fujita M; Ito-Fujita Y; Iyoda T; Sasada M; Okada Y; Ishibashi K; Osawa T; Kodama H; Fukai F; Suzuki H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195598
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells.
Murase W; Kamakura Y; Kawakami S; Yasuda A; Wagatsuma M; Kubota A; Kojima H; Ohta T; Takahashi M; Mutoh M; Tanaka T; Maeda H; Miyashita K; Terasaki M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948416
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane.
Suzuki R; Kohno H; Sugie S; Tanaka T
Histol Histopathol; 2005 Apr; 20(2):483-92. PubMed ID: 15736053
[TBL] [Abstract][Full Text] [Related]
16. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
Fichera A; Little N; Dougherty U; Mustafi R; Cerda S; Li YC; Delgado J; Arora A; Campbell LK; Joseph L; Hart J; Noffsinger A; Bissonnette M
J Surg Res; 2007 Oct; 142(2):239-45. PubMed ID: 17574271
[TBL] [Abstract][Full Text] [Related]
17. Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate.
Suzuki R; Miyamoto S; Yasui Y; Sugie S; Tanaka T
BMC Cancer; 2007 May; 7():84. PubMed ID: 17506908
[TBL] [Abstract][Full Text] [Related]
18. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
19. [Changes of expression of miR-155 in colitis-associated colonic carcinogenesis].
Li W; Han W; Zhao X; Wang H
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):257-62. PubMed ID: 24989910
[TBL] [Abstract][Full Text] [Related]
20. Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development.
Prieto SP; Reed CL; James HM; Quinn KP; Muldoon TJ
BMC Cancer; 2019 May; 19(1):428. PubMed ID: 31072353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
